Clinical Trial Update: Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pharmacodynamic effects of sibutramine on gastric function in obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Sibutramine (sibutramine)

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED